ReviewTargeted oncology2024
Divarasib in the Evolving Landscape of KRAS G12C Inhibitors for NSCLC.
Danielle Brazel et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this papertrialcites it
ReviewTargeted oncology2024
Danielle Brazel et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.